• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Proton pump inhibitors are associated with a reduced likelihood for sexually transmitted diseases in women in the emergency department.质子泵抑制剂与急诊科女性性传播疾病的发病可能性降低有关。
Indian J Sex Transm Dis AIDS. 2017 Jan-Jun;38(1):60-64. doi: 10.4103/0253-7184.203438.
2
Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic.一家性传播疾病诊所男性患者中阴道毛滴虫感染的比较患病率。
Sex Transm Dis. 2000 Apr;27(4):236-40. doi: 10.1097/00007435-200004000-00010.
3
Is the presence of Trichomonas vaginalis a reliable predictor of coinfection with Chlamydia trachomatis and/or Neisseria gonorrhoeae in female ED patients?在女性急诊患者中,阴道毛滴虫的存在是否是沙眼衣原体和/或淋病奈瑟菌合并感染的可靠预测指标?
Am J Emerg Med. 2005 Mar;23(2):127-30. doi: 10.1016/j.ajem.2004.04.029.
4
The prevalence of chlamydia, gonorrhea, and trichomonas in sexual partnerships: implications for partner notification and treatment.性伴侣中衣原体、淋病和滴虫的流行情况:对性伴侣通知和治疗的影响。
Sex Transm Dis. 2005 Apr;32(4):260-4. doi: 10.1097/01.olq.0000161089.53411.cb.
5
Coinfection with Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis: a cross-sectional analysis of positivity and risk factors in remote Australian Aboriginal communities.沙眼衣原体、淋病奈瑟菌和阴道毛滴虫混合感染:澳大利亚偏远原住民社区阳性率及危险因素的横断面分析
Sex Transm Infect. 2015 May;91(3):201-6. doi: 10.1136/sextrans-2014-051535. Epub 2014 Oct 28.
6
Molecular-based Testing for Sexually Transmitted Infections Using Samples Previously Collected for Vaginitis Diagnosis.基于分子的性传播感染检测,使用先前为阴道炎诊断采集的样本。
Clin Infect Dis. 2019 Jan 18;68(3):375-381. doi: 10.1093/cid/ciy504.
7
Duration of polymerase chain reaction-detectable DNA after treatment of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis infections in women.女性沙眼衣原体、淋病奈瑟菌和阴道毛滴虫感染治疗后聚合酶链反应可检测到的 DNA 持续时间。
Sex Transm Dis. 2014 Mar;41(3):215-9. doi: 10.1097/OLQ.0000000000000102.
8
High prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and particularly Trichomonas vaginalis diagnosed using US FDA-approved Aptima molecular tests and evaluation of conventional routine diagnostic tests in Ternopil, Ukraine.在乌克兰特尔诺皮尔,使用美国食品和药物管理局批准的 Aptima 分子检测方法诊断出沙眼衣原体、淋病奈瑟菌的高流行率,特别是阴道毛滴虫。同时评估了常规常规诊断检测。
APMIS. 2019 Sep;127(9):627-634. doi: 10.1111/apm.12975.
9
Prevalence of Trichomonas vaginalis infection in symptomatic adolescent females presenting to a pediatric emergency department.就诊于儿科急诊的有症状青少年女性阴道毛滴虫感染的流行率。
Acad Emerg Med. 2011 Jul;18(7):763-6. doi: 10.1111/j.1553-2712.2011.01111.x.
10
Diagnosis of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and Mycoplasma genitalium: an observational study of testing patterns, prevalence and co-infection rates in northern New Zealand.沙眼衣原体、淋病奈瑟菌、阴道毛滴虫和生殖支原体的诊断:新西兰北部检测模式、患病率及合并感染率的观察性研究
Sex Health. 2018 Jun;15(3):232-237. doi: 10.1071/SH17110.

本文引用的文献

1
Identification of proton-pump inhibitor drugs that inhibit Trichomonas vaginalis uridine nucleoside ribohydrolase.鉴定抑制阴道毛滴虫尿苷核苷核糖水解酶的质子泵抑制剂药物。
Bioorg Med Chem Lett. 2014 Feb 15;24(4):1080-4. doi: 10.1016/j.bmcl.2014.01.014. Epub 2014 Jan 13.
2
Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: new concepts and controversies.妇产科临床中的阴道毛滴虫阴道炎:新概念与争议。
Obstet Gynecol Surv. 2013 Jan;68(1):43-50. doi: 10.1097/OGX.0b013e318279fb7d.
3
Glycogen accumulation and degradation by the trichomonads Trichomonas vaginalis and Trichomonas tenax.阴道毛滴虫和坚韧毛滴虫的糖原积累和降解。
J Eukaryot Microbiol. 2012 Jul-Aug;59(4):359-66. doi: 10.1111/j.1550-7408.2012.00624.x. Epub 2012 May 21.
4
Antiprotozoal activity of proton-pump inhibitors.质子泵抑制剂的抗原生动物活性。
Bioorg Med Chem Lett. 2011 Dec 15;21(24):7351-4. doi: 10.1016/j.bmcl.2011.10.028. Epub 2011 Oct 14.
5
Proton pump inhibitors: an update of their clinical use and pharmacokinetics.质子泵抑制剂:临床应用及药代动力学的最新进展
Eur J Clin Pharmacol. 2008 Oct;64(10):935-51. doi: 10.1007/s00228-008-0538-y. Epub 2008 Aug 5.
6
Trichomonas vaginalis Weakens human Amniochorion in an in vitro model of premature membrane rupture.在胎膜早破的体外模型中,阴道毛滴虫会削弱人羊膜绒毛膜。
Infect Dis Obstet Gynecol. 1995;2(6):267-74. doi: 10.1155/S1064744995000160.
7
Trichomoniasis.滴虫病
Clin Microbiol Rev. 2004 Oct;17(4):794-803, table of contents. doi: 10.1128/CMR.17.4.794-803.2004.
8
Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.耐甲硝唑阴道毛滴虫引起的感染的治疗。
Clin Microbiol Rev. 2004 Oct;17(4):783-93, table of contents. doi: 10.1128/CMR.17.4.783-793.2004.
9
Pyruvate decarboxylase, the target for omeprazole in metronidazole-resistant and iron-restricted Tritrichomonas foetus.丙酮酸脱羧酶,甲硝唑耐药且铁限制条件下胎儿三毛滴虫中奥美拉唑的作用靶点。
Antimicrob Agents Chemother. 2004 Jun;48(6):2185-9. doi: 10.1128/AAC.48.6.2185-2189.2004.
10
Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000.2000年美国青少年性传播疾病:发病率及流行率估计
Perspect Sex Reprod Health. 2004 Jan-Feb;36(1):6-10. doi: 10.1363/psrh.36.6.04.

质子泵抑制剂与急诊科女性性传播疾病的发病可能性降低有关。

Proton pump inhibitors are associated with a reduced likelihood for sexually transmitted diseases in women in the emergency department.

作者信息

Sheele Johnathan Michael, Morris Nathan, Byars Donald, Counselman Frank

机构信息

Department of Emergency Medicine, University Hospitals Cleveland Medical Center & Case Western Reserve University, Cleveland, OH 44106, USA.

Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH 44106, USA.

出版信息

Indian J Sex Transm Dis AIDS. 2017 Jan-Jun;38(1):60-64. doi: 10.4103/0253-7184.203438.

DOI:10.4103/0253-7184.203438
PMID:28442805
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5389217/
Abstract

BACKGROUND

Proton pump inhibitors (PPIs) have been shown in cell culture to kill (TV) at lower half maximal inhibitory concentration values than metronidazole (Flagyl), the most common medication used to treat the infection. However, there have been no previous clinical investigations to determine if PPIs are associated with reduced risk for TV.

MATERIALS AND METHODS

We examined the records of female patients who received testing in the emergency department for TV, (GC), and (CT) between 2010 and 2014 at two academic medical centers to determine if PPI and histamine type 2 receptor antagonist (H2RA) drugs were associated with TV and GC/CT infections.

RESULTS

We found that H2RAs were associated with an increased likelihood for TV (odds ratio [OR]: 2.0, < 0.0001) and GC and/or CT infections (OR: 1.49, < 0.0001). PPIs were associated with a reduced likelihood for TV (OR: 0.75, < 0.0001) and GC and/or CT infections (OR: 0.57, < 0.0001). In patients infected with GC and/or CT, the likelihood of coinfection with TV was reduced in those taking a PPI (OR: 0.64, = 0.054) and increased in those taking an H2RA (OR: 1.62, = 0.003).

CONCLUSIONS

PPIs are associated with a reduced risk for TV and GC/CT infection.

摘要

背景

在细胞培养中已表明,质子泵抑制剂(PPI)在达到半数最大抑制浓度值时杀灭沙眼衣原体(TV)的效果优于甲硝唑(灭滴灵),后者是治疗该感染最常用的药物。然而,此前尚无临床研究确定PPI是否与降低TV感染风险相关。

材料与方法

我们查阅了2010年至2014年间在两家学术医疗中心急诊科接受TV、淋病奈瑟菌(GC)和沙眼衣原体(CT)检测的女性患者记录,以确定PPI和2型组胺受体拮抗剂(H2RA)药物是否与TV及GC/CT感染相关。

结果

我们发现H2RA与TV感染可能性增加相关(比值比[OR]:2.0,P<0.0001)以及与GC和/或CT感染相关(OR:1.49,P<0.0001)。PPI与TV感染可能性降低相关(OR:0.75,P<0.0001)以及与GC和/或CT感染相关(OR:0.57,P<0.0001)。在感染GC和/或CT的患者中,服用PPI的患者合并感染TV的可能性降低(OR:0.64,P = 0.054),而服用H2RA的患者合并感染TV的可能性增加(OR:1.62,P = 0.003)。

结论

PPI与降低TV及GC/CT感染风险相关。